Neuroelectrics Announces Results of Telemedicine Pilot Depression Study with Starstim tDCS Therapy

• 64% median percentage reduction in observer-rated MADRS scores, indicating significant and clinically meaningful improvement in depressive symptoms, with over 70% of participants demonstrating a ≥50% improvement.
• 73% response rate highlights the potential of at-home remotely-supervised tDCS therapy with Starstim as a potential safe and effective option for individuals with MDD.
• Nearly 90% of participants completed the full course of home-based transcranial direct current stimulation (tDCS) using Neuroelectrics’ Starstim device without adverse effects.

CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Neuroelectrics  announced today study results published to the preprint server  medRxiv  that suggest tele-supervised at-home transcranial direct current stimulation (tDCS) using Starstim over the left dorsolateral prefrontal cortex (L-DLPFC) may improve the clinical symptoms of major depressive disorder (MDD).